Novartis | NOVN - Market Capitalization

Stock Price
121.52
Daily Change
-1.68 -1.36%
Monthly
-3.02%
Yearly
37.09%
Q2 Forecast
120.10

Novartis reported $251.82B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Alcon AG USD 31.08B 1.97B Dec/2025
Almirall EUR 2.76B 472.53M Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Bayer EUR 36.36B 9.13B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Fresenius EUR 27.59B 889.91M Dec/2025
Fresenius Medical Care EUR 11.96B 1.14B Dec/2025
Galapagos EUR 1.85B 76.44M Dec/2025
Genmab DKK 20.48B 1.02B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 53.3B 5.72B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Novartis USD 263.08B 17.01B Dec/2025
Novo Nordisk A/S DKK 1.45T 86.62B Dec/2025
Orion EUR 8.94B 243.74M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Philips EUR 22.38B 192.58M Dec/2025
Recordati EUR 10.15B 660.84M Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 46.41B 13.94B Dec/2025